16
Views
11
CrossRef citations to date
0
Altmetric
Research Article

Antiretroviral Treatment of Human Immunodeficiency Virus Infection: Swedish Recommendations

, , , , , , , , & show all
Pages 155-167 | Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Lars-Magnus Andersson, Jan Vesterbacka, Anders Blaxhult, Leo Flamholc, Staffan Nilsson, Vidar Ormaasen, Anders Sönnerborg & Magnus Gisslén. (2013) Lopinavir/ritonavir, atazanavir/ritonavir, and efavirenz in antiretroviral-naïve HIV-1-infected individuals over 144 weeks: An open-label randomized controlled trial. Scandinavian Journal of Infectious Diseases 45:7, pages 543-551.
Read now

Articles from other publishers (10)

Enrico Ripamonti, Arvid Edén, Staffan Nilsson, Anders Sönnerborg, Henrik Zetterberg & Magnus Gisslén. (2022) Longitudinal decline of plasma neurofilament light levels after antiretroviral initiation in people living with HIV. Journal of Internal Medicine 293:4, pages 445-456.
Crossref
Ujjwal Neogi, Abu Bakar Siddik, Prabhav Kalaghatgi, Magnus Gisslén, Göran Bratt, Gaetano Marrone & Anders Sönnerborg. (2017) Recent increased identification and transmission of HIV-1 unique recombinant forms in Sweden. Scientific Reports 7:1.
Crossref
Ujjwal Neogi, Amanda Häggblom, Michele Santacatterina, Göran Bratt, Magnus Gisslén, Jan Albert & Anders Sonnerborg. (2014) Temporal Trends in the Swedish HIV-1 Epidemic: Increase in Non-B Subtypes and Recombinant Forms over Three Decades. PLoS ONE 9:6, pages e99390.
Crossref
Anna Fugelstad, Anders Annell & Gunnar Ågren. (2014) Long-term mortality and causes of death among hospitalized Swedish drug users. Scandinavian Journal of Public Health 42:4, pages 364-369.
Crossref
Fu-jie ZHANG, Maria Au, Jessica Haberer & Yan ZHAO. (2006) Overview of HIV drug resistance and its implications for China. Chinese Medical Journal 119:23, pages 1999-2004.
Crossref
Björn Södergård, Margit Halvarsson, Stefan Lindbäck, Anders Sönnerborg, Mary P. Tully & Åsa Kettis Lindblad. (2006) Differences in adherence and motivation to HIV therapy—two independent assessments in 1998 and 2002. Pharmacy World & Science 28:4, pages 248-256.
Crossref
Ola Nordqvist, Björn Södergård, Mary Patricia Tully, Anders Sönnerborg & Åsa Kettis Lindblad. (2006) Assessing and achieving readiness to initiate HIV medication. Patient Education and Counseling 62:1, pages 21-30.
Crossref
Ulrik Stenz Justesen. (2006) Therapeutic Drug Monitoring and Human Immunodeficiency Virus (HIV) Antiretroviral Therapy. Basic <html_ent glyph="@amp;" ascii="&"/> Clinical Pharmacology <html_ent glyph="@amp;" ascii="&"/> Toxicology 98:1, pages 20-31.
Crossref
Philip Roels. (2004) Ocular manifestations of AIDS: new considerations for patients using highly active anti-retroviral therapy (HAART). Optometry - Journal of the American Optometric Association 75:10, pages 624-628.
Crossref
A-M Vandamme, A Sönnerborg, M Ait-Khaled, J Albert, B Asjo, L Bacheler, D Banhegyi, C Boucher, F Brun-Vézinet, R Camacho, P Clevenbergh, N Clumeck, N Dedes, A De Luca, HW Doerr, J-L Faudon, G Gatti, J Gerstoft, WW Hall, A Hatzakis, N Hellmann, A Horban, JD Lundgren, D Kempf, M Miller, V Miller, TW Myers, C Nielsen, M Opravil, L Palmisano, CF Perno, A Phillips, D Pillay, T Pumarola, L Ruiz, M Salminen, J Schapiro, B Schmidt, J-C Schmit, R Schuurman, E Shulse, V Soriano, S Staszewski, S Vella, M Youle, R Ziermann & L Perrin. (2004) Updated European Recommendations for the Clinical Use of HIV Drug Resistance Testing. Antiviral Therapy 9:6, pages 829-848.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.